Interdisciplinary research consortia

Interdisciplinary research consortia bring together researchers from different fields to integrate their knowledge and expertise around a specific research topic. Through this cross-fertilisation, understanding of various disease states can be increased, diagnoses improved and alternative treatments developed. The research consortia below are active at the faculty (non-exhaustive).

Cancer Research Institute Ghent (CRIG)

CRIG’s mission is to stimulate fundamental, translational and clinical cancer research across expertise domains to achieve better and faster outcomes for cancer patients.

Cross-Health platform (XH)

Within the Cross-Health platform, the fields of veterinary and human medicine, plant biotechnology, bio-engineering, medicinal chemistry and data sciences collaborate to develop applications benefitting human and/or animal health.

Ghent Gut Inflammation Group (GGIG)

GGIG represents a consortium studying diverse aspects of gastrointestinal biology during health and disease. Understanding how the complex interactions between the intestinal microbiota and host immune as well as stromal cells affect both intestinal and extra-intestinal health (e.g. in the brain and the joints) demands a multi-disciplinary approach.

Ghent University Research for Aging Young (GRAY)

GRAY is an interdisciplinary consortium aimed at boosting healthy ageing through excellent translational research, societal impact and valorisation of new solutions, interventions, products and services. GRAY brings together the expertise of health promotion, environments and urbanisation, adaptive technologies, societal valorisation and basic research within the field of ageing and closes the gap between science and society.

UGent @ Work

UGent @ Work is an interdisciplinary research consortium aimed at realising societal impact with UGent research on work and the labour market. Areas involved include occupational health, impact of the work environment on employee health and well-being, health economics.

U(Z)Gent platform of gene, cell and tissue engineering (GATE)

GATE fosters multidisciplinary collaborations to accelerate the creation and commercialization of cell and tissue engineering research. This includes a broad scope of technologies and expertise applicable to gene and cell therapy, artificial organ systems and regenerative medicine.